Boehringer Ingelheim Venture Fund Investor
Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
Technology:
DeepTech
Industry:
Longevity Industry 2022
Headquarters:
Ingelheim Am Rhein, Rheinland-Pfalz, Germany
Zip:
NA
Founded Date:
2010-01-01
Employees Number:
11-50
Investor Type:
Corporate Venture Capital
Investment Stage:
Early Stage Venture, Seed
Number Of Exits:
8
Acquisitions Number:
8
Investors Number:
NA
Estimated Revenue:
$1M to $10M
Register and Claim Ownership